MedTrace Logo

VALID : VAlproate Versus LIthium in Bipolar Disorders

NCT00264173 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2007-11-16

No results posted yet for this study

Summary

Primary Objective :

* To compare the efficacy of valproate to lithium in Bipolar I patients suffering from a manic or a mixed episode according to DSM IV TR (APA 2000) \[Diagnostic and Statistical Manual of Mental Disorders (DSM) fourth edition (IV)Text Revision (TR)\] and over a periode of 3 weeks and 12 weeks of treatment

Secondary Objective :

* To evaluate the clinical and biological safety of valproate compared to lithium.

Conditions

Interventions

DRUG

Valproate sodium

Sponsors & Collaborators

Principal Investigators

  • Robert MANFREDI, MD · Sanofi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Completion
2006-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264173 on ClinicalTrials.gov